All regulatory updates
1479 results found
ECHA added n-hexane to the REACH Candidate List (SVHC)
ECHA’s official REACH Candidate List table shows n-hexane (EC 203-777-6; CAS 110-54-3) added to the Candidate List with date of inclusion 04-Feb-2026, identified as an SVHC under Article 57(f) (human health) for specific target organ toxicity after repeated exposure (STOT RE). This addition triggers downstream REACH Candidate List obligations for supply chains (e.g., Article 33 communication for articles, and related SVHC information management).
ECHA Member State Committee meeting highlights indicate two substances will be added to the REACH SVHC Candidate List in February 2026 (n-hexane and BPAF)
ECHA’s Member State Committee (MSC) meeting highlights indicate that ECHA will add two substances to the REACH Candidate List in February 2026, as reflected by secondary sources as occurring on 4 February 2026. The substances referenced are n-hexane (identified as SVHC on an ‘equivalent level of concern’ basis) and 4,4′-[2,2,2-trifluoro-1-(trifluoromethyl)ethylidene]diphenol and its salts (often referred to as BPAF in secondary sources). Candidate List inclusion is significant for compliance teams because it triggers downstream REACH SVHC obligations for articles and substances/mixtures where applicable (e.g., Article 33 communication duties and potential Article 7(2) notification considerations), and typically drives immediate supply-chain data collection and product screening workflows.
ECHA Registry of SVHC intentions until outcome updated (pipeline/status tracker)
ECHA updated its official "Registry of SVHC intentions until outcome" (page shows last updated 04 Feb 2026). While not a Candidate List change itself, this is an official process/status tracking update used by compliance teams to monitor forthcoming SVHC identification dossiers and their progression through the REACH Article 59 process.
EU proposes TBPH for Stockholm Convention Annex A/B listing
The European Commission has proposed a Council Decision authorizing the EU to submit a proposal for listing bis(2-ethylhexyl) tetrabromophthalate (TBPH) in Annex A or Annex B to the Stockholm Convention. TBPH is a brominated flame retardant used in plastics, electronics, construction materials, and wire insulation. If the Council adopts this decision, the EU will formally submit the TBPH nomination to the Stockholm Convention, initiating the POPRC review process for potential global restriction under the Convention.
Cambodia removed from EAR Country Group D:5
The Bureau of Industry and Security (BIS) published a final rule removing Cambodia from Country Group D:5 (U.S. Arms Embargoed Countries) under the Export Administration Regulations (EAR). This conforming change aligns the EAR with the November 7, 2025 revision to ITAR § 126.1 that removed the U.S. arms embargo on Cambodia. However, compliance teams should note that Cambodia remains in Country Group D:1 (National Security restrictions), and military end-user restrictions under EAR § 744.21 and military-intelligence end-user restrictions under EAR § 744.22 remain in effect. Certain license requirements for exports and reexports to Cambodia continue to apply based on these ongoing controls.
ECHA opened consultation on the 13th draft recommendation to include SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its 13th draft recommendation for prioritising Candidate List SVHCs for inclusion in REACH Annex XIV (Authorisation List). The consultation runs from 2 February 2026 to 2 May 2026. If finalised and later adopted by the European Commission, Annex XIV inclusion would introduce authorisation obligations (including latest application and sunset dates). Compliance teams should review the draft recommendation and background documents, assess portfolio impacts for listed SVHCs, and consider submitting comments.
ECHA opens public consultation on draft 13th recommendation to include Candidate List SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its draft 13th recommendation to include certain SVHC Candidate List substances in REACH Annex XIV (Authorisation List). This is an upstream step toward potential Annex XIV inclusion (which would later impose authorisation requirements and set latest application and sunset dates via subsequent Commission action). Compliance teams should review whether any recommended substances are used in products/processes and consider submitting comments and preparing for potential authorisation planning and supply-chain communication.
ECHA publishes Draft 13th Recommendation documents for potential inclusion of priority SVHCs in REACH Annex XIV (Authorisation List)
ECHA published supporting documents for its Draft 13th Recommendation of priority substances for potential inclusion in REACH Annex XIV (Authorisation List), including draft Annex XIV entry structures and background/prioritisation documents. This is a draft/pipeline step (not yet a binding Annex XIV amendment), but it signals which SVHCs may be advanced toward authorisation requirements, informing early substitution planning and monitoring of latest application date/sunset date proposals once finalized by the European Commission.
ECHA opens consultation on draft recommendation to include four Candidate List substances in the REACH Authorisation List (Annex XIV)
ECHA launched a public consultation on its draft recommendation to the European Commission to add four Candidate List substances to the REACH Authorisation List (Annex XIV). Compliance teams should monitor this pipeline step because Annex XIV inclusion can introduce authorisation obligations for continued use/placing on the market (subject to future sunset dates set in any eventual Annex XIV entries). The consultation is open for stakeholder input until 2 May 2026.
ECHA opened public consultation on the Draft 13th Recommendation to include four SVHCs in the REACH Authorisation List (Annex XIV)
ECHA published the Draft 13th Recommendation and opened a public consultation (2 Feb 2026 to 2 May 2026) on prioritising four SVHCs for potential inclusion in the REACH Authorisation List (Annex XIV): bumetrizole (UV-326), UV-329, triphenyl phosphate, and 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-one. This consultation is a key step in the SVHC-to-authorisation pathway; affected companies should assess uses and consider submitting evidence on uses, alternatives, and socio-economic impacts.
ECHA opens public consultation on draft recommendation to include four Candidate List substances in REACH Authorisation List (Annex XIV)
ECHA opened a public consultation on its draft recommendation to the European Commission to include four SVHC Candidate List substances in REACH Annex XIV (Authorisation List). Stakeholders are invited to submit information (e.g., uses, volumes, potential exemptions, and supply chain impacts) to inform ECHA’s final recommendation. This is a proposed/pipeline step (not yet a legal Annex XIV amendment) but is highly relevant for companies using these substances, as Annex XIV listing can lead to authorisation obligations and potential phase-out/substitution planning.
ECHA opened public consultation on the draft 13th recommendation for inclusion of Candidate List SVHCs in REACH Annex XIV (Authorisation List)
ECHA published the draft 13th recommendation for inclusion of Candidate List substances of very high concern (SVHCs) in REACH Annex XIV (Authorisation List) and opened a public consultation. This is a key downstream step in the SVHC pathway because Annex XIV listing can ultimately require companies to obtain authorisation for continued use/placing on the market of listed substances after specified sunset dates (once Annex XIV is formally amended via EU legislation). Compliance teams should review whether any substances relevant to their portfolios are covered and consider preparing comments and internal substitution/authorisation strategies.
ECHA opens public consultation on draft 13th recommendation to include Candidate List SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its draft 13th recommendation to include certain SVHC Candidate List substances in REACH Annex XIV (Authorisation List). This is an upstream step toward potential Annex XIV inclusion (which would later impose authorisation requirements and set latest application and sunset dates via subsequent Commission action). Compliance teams should review whether any recommended substances are used in products/processes and consider submitting comments and preparing for potential authorisation planning and supply-chain communication.
ECHA opens public consultation on draft 13th recommendation for inclusion of SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its draft 13th recommendation for prioritising certain Candidate List SVHCs for inclusion in REACH Annex XIV (Authorisation List). The consultation period runs from 2 February 2026 to 2 May 2026. This is a key SVHC-to-authorisation pipeline milestone: affected manufacturers/importers/downstream users should review whether any of the recommended substances are in their supply chains and consider submitting comments, as future Annex XIV inclusion can lead to authorisation obligations and phase-out pressures.
ECHA opens public consultation on draft 13th recommendation to include Candidate List SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its draft 13th recommendation for inclusion of certain Candidate List SVHCs in REACH Annex XIV (Authorisation List). This is a key SVHC-related downstream step: substances recommended for Annex XIV can later be added by the European Commission via amendment, triggering authorisation requirements (including latest application and sunset dates) for continued use. Consultation window shown is 02 Feb 2026 to 02 May 2026, with linked draft recommendation and supporting documents.
ECHA opened public consultation on the Draft 13th Recommendation to include four SVHCs in the REACH Authorisation List (Annex XIV)
ECHA published the Draft 13th Recommendation and opened a public consultation (2 Feb 2026 to 2 May 2026) on prioritising four SVHCs for potential inclusion in the REACH Authorisation List (Annex XIV): bumetrizole (UV-326), UV-329, triphenyl phosphate, and 2-(dimethylamino)-2-[(4-methylphenyl)methyl]-1-[4-(morpholin-4-yl)phenyl]butan-1-one. This consultation is a key step in the SVHC-to-authorisation pathway; affected companies should assess uses and consider submitting evidence on uses, alternatives, and socio-economic impacts.
ECHA opens public consultation on draft 13th recommendation to include Candidate List SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its draft 13th recommendation for inclusion of certain Candidate List SVHCs in REACH Annex XIV (Authorisation List). This is a key SVHC-related downstream step: substances recommended for Annex XIV can later be added by the European Commission via amendment, triggering authorisation requirements (including latest application and sunset dates) for continued use. Consultation window shown is 02 Feb 2026 to 02 May 2026, with linked draft recommendation and supporting documents.
ECHA opens public consultation on draft 13th recommendation for inclusion of SVHCs in REACH Annex XIV (Authorisation List)
ECHA opened a public consultation on its draft 13th recommendation for prioritising certain Candidate List SVHCs for inclusion in REACH Annex XIV (Authorisation List). The consultation period runs from 2 February 2026 to 2 May 2026. This is a key SVHC-to-authorisation pipeline milestone: affected manufacturers/importers/downstream users should review whether any of the recommended substances are in their supply chains and consider submitting comments, as future Annex XIV inclusion can lead to authorisation obligations and phase-out pressures.
ECHA opens public consultation on the draft 13th recommendation for inclusion of Candidate List SVHCs in REACH Annex XIV (Authorisation List) (02 Feb 2026–02 May 2026)
ECHA has opened a public consultation on its draft 13th recommendation of priority SVHCs from the Candidate List for possible inclusion in REACH Annex XIV (Authorisation List). The consultation window shown is 02 February 2026 through 02 May 2026. This is a key step in the SVHC-to-authorisation pipeline; if substances are later added to Annex XIV by the European Commission, authorisation requirements could apply for non-exempt uses after future latest application/sunset dates. Compliance teams should evaluate business impacts, substitution plans, and consider submitting comments/evidence during the consultation period.
ECHA opens public consultation on the draft 13th recommendation for inclusion of Candidate List SVHCs in REACH Annex XIV (Authorisation List) (02 Feb 2026–02 May 2026)
ECHA has opened a public consultation on its draft 13th recommendation of priority SVHCs from the Candidate List for possible inclusion in REACH Annex XIV (Authorisation List). The consultation window shown is 02 February 2026 through 02 May 2026. This is a key step in the SVHC-to-authorisation pipeline; if substances are later added to Annex XIV by the European Commission, authorisation requirements could apply for non-exempt uses after future latest application/sunset dates. Compliance teams should evaluate business impacts, substitution plans, and consider submitting comments/evidence during the consultation period.